Table 1.

Initial and final body weight, femoral length, and BMC of mice treated with PTH or ABL for 21 days.

	Baseline	Ctrl	PTH	ABL
Body weight (g) (study start)	20.8 ± 1.5	21. 2 ± 0.9	21. 2 ± 0.9	21.3 ± 1.3
Body weight (g) (study end)	20.8 ± 1.5	21.9 ± 1.1	22.7 ± 1.0	22.9 ± 1.5
Femoral length (mm)	15.3 ± 0.3	15.8 ± 0.3	15.7 ± 0.3	15.7 ± 0.3
aBMD (mg/cm2)	57.0 ± 1.9	63.6 ± 2.2	66.2 ± 3.4	67.1 ± 3.6*
BMC (mg)	19.6 ± 1.2	22.8 ± 1.5	24.0 ± 1.5	23.8 ± 2.0

aBMD, areal bone mineral density; BMC, bone mineral content. Data are presented as mean ± SD.